Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 400

Sort by

Sort Order Select

Journal Articles

RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma

Martina Emde, Susanne Beck, Vladimir Benes, Jerome Moreaux, PhD, Anja Seckinger, Dirk Hose, MD

Blood (2019) 134 (Supplement_1): 1801.

https://doi.org/10.1182/blood-2019-131159

Published: 2019

Journal Articles

The Role of Hypoxia on ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells

Seiichi Okabe, MD PhD, Yuko Tanaka, MD PhD, Mitsuru Moriyama, Akihiko Gotoh, MD PhD

Blood (2019) 134 (Supplement_1): 5369.

https://doi.org/10.1182/blood-2019-129768

Published: 2019

Journal Articles

MCT1 As Molecularly Validated Predictive Marker for Lenalidomide-Maintenance Therapy in Multiple Myeloma

Jacob Stroh, Anja Seckinger, Michael Heider, Ruth Eichner, Martina Emde, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, MD, Katja Weisel, Christof Scheid, MD, Dirk Hose, MD, Florian Bassermann, MD PhD

Blood (2019) 134 (Supplement_1): 3187.

https://doi.org/10.1182/blood-2019-130734

Published: 2019

Journal Articles

Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Cristina Panaroni, PhD, Keertik Fulzele, PhD, Rosemary Soucy, Cherrie Huang, Kenta Mukaihara, MD PhD, Shrikanta Chattopadhyay, MBBS, Noopur S. Raje, MD

Blood (2019) 134 (Supplement_1): 3108.

https://doi.org/10.1182/blood-2019-131906

Published: 2019

Journal Articles

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

Michael Ellison, PhD, Natalie Briones, MS, Angelina Baroffio, John Murphy, Katherine Gowan, Bridget Sanford, Kenneth L. Jones, PhD, Daniel R. Ambruso, MD

Blood (2018) 132 (Supplement 1): 2398.

https://doi.org/10.1182/blood-2018-99-115314

Published: 2018

Journal Articles

CD25 (IL2RA) Is a Direct Transcriptional Target of PRDM1 in Activated Human Natural Killer Cells

Burcu Akman, M.S., Deniz Kursun, Tevfik Hatipoglu, Xiaozhou Hu, MD, Wing C Chan, MD, Can Kucuk, PhD

Blood (2018) 132 (Supplement 1): 3724.

https://doi.org/10.1182/blood-2018-99-113460

Published: 2018

Journal Articles

Crosstalk between the IGF1 and CXCL12 Pathways Defines Objective Responses to the Farnesyl Transferase Inhibitor Tipifarnib in AML and PTCL Patients

Antonio Gualberto, PhD MD, Catherine Scholz, PharmD, Vishnu Mishra, PhD, Matthew R Janes, PhD, Linda Kessler, BA

Blood (2018) 132 (Supplement 1): 5349.

https://doi.org/10.1182/blood-2018-99-116969

Published: 2018

Journal Articles

SLAMF7 high CD16 negative Monocytes Increase in Peripheral Blood of Patients with Myelofibrosis in Correlation with JAK2V617F Mutation

Takaaki Maekawa, MD, Shoichiro Kato, MD, Yosuke Okada, MD, Noriaki Tachi, MD, Masahiro Teramoto, MD, Toshikuni Kawamura, MD, Yukiko Osawa, PhD, Shinichi Kobayashi, MD PhD, Ken Sato, MD PhD, Michihiro Hashimoto, PhD, Shinya Suzu, PhD, Kensuke Usuki, MD PhD, Soji Morishita, PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Fumihiko Kimura, Prof, MD PhD

Blood (2018) 132 (Supplement 1): 4330.

https://doi.org/10.1182/blood-2018-99-110916

Published: 2018

Journal Articles

Interleukin 1 Beta As a Promising Therapeutic Target in ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells

Seiichi Okabe, MD PhD, Tetsuzo Tauchi, MD PhD, Yuko Tanaka, Kazuma Ohyashiki, MD PhD

Blood (2018) 132 (Supplement 1): 4249.

https://doi.org/10.1182/blood-2018-99-114030

Published: 2018

Journal Articles

Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

Blood (2018) 132 (Supplement 1): 4485.

https://doi.org/10.1182/blood-2018-99-113284

Published: 2018

Journal Articles

Upregulation of PD-L1 on Myeloma Cells By Immunomodulatory Agents Potentiates the Effect of Durvalumab

Mariko Ishibashi, PhD, Junichi Yamamoto, PhD, Takumi Ito, PhD, Hiroshi Handa, MD PhD, Koiti Inokuchi, MD PhD, Hidemi Takahashi, MD PhD, Hideto Tamura, MD PhD

Blood (2018) 132 (Supplement 1): 4439.

https://doi.org/10.1182/blood-2018-99-112322

Published: 2018

Journal Articles

Targeting Tryptophan Catabolic Kynurenine Pathway Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Arghya Ray, PhD, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2018) 132 (Supplement 1): 1930.

https://doi.org/10.1182/blood-2018-99-117827

Published: 2018

Journal Articles

Genotypic and Phenotypic Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Interim Report of a Multi-Center Study

Lakshmi Srivaths, MD, Jorge Di Paola, MD, Charles Minard, PhD, Sarah H. O'Brien, MD MSc, Allison Wheeler, MD, Shilpa Jain, MDMPH, Mukta Sharma, MD MPH, Roshni Kulkarni, Eric S. Mullins, MD, Margaret V. Ragni, MD MPH, Jennifer Dietrich, Peter A. Kouides, MD

Blood (2018) 132 (Supplement 1): 984.

https://doi.org/10.1182/blood-2018-99-113064

Published: 2018

Journal Articles

Identification of Alpha-Enolase (ENO1) As a Novel Immunometabolic Target in Multiple Myeloma

Arghya Ray, PhD, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD

Blood (2018) 132 (Supplement 1): 594.

https://doi.org/10.1182/blood-2018-99-117757

Published: 2018

Journal Articles

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

Konstantinos Christofyllakis, MD, Frank Neumann, PhD, Stephan Stilgenbauer, Dominic Kaddu-Mulindwa, MD, Evi Regitz, Moritz Bewarder, MD, Andreas Keller, PhD MSc, Jörg Thomas Bittenbring, MD

Blood (2018) 132 (Supplement 1): 3696.

https://doi.org/10.1182/blood-2018-99-111817

Published: 2018

Journal Articles

Pediatric LSC3 (pLSC3) Score Derived from DNMT3B-CD34-GPR56 As a Prognostic Tool to Predict AML Patient Outcome: Results from Two Independent Pediatric AML Cohorts

Abdelrahman H Elsayed, MSc, Huiyun Wu, PhD, Xueyuan Cao, PhD, Susana C. Raimondi, PhD, James R. Downing, MD, Raul Ribeiro, MD, Tanja A. Gruber, MD PhD, Jeffrey Rubnitz, MD PhD, Stanley Pounds, PhD, Jatinder K Lamba, PhD

Blood (2018) 132 (Supplement 1): 290.

https://doi.org/10.1182/blood-2018-99-116462

Published: 2018

Journal Articles

Metabolic Reprogramming of Dendritic Cells Is Controlled By the Mir-142

Yaping Sun, MD PhD MS, Thomas Saunders, PhD, Katherine Oravecz-Wilson, BS, MS, Sydney Bridges, BS, Richard McEachin, PhD, Julia Wu, PhD, Stephanie Kim, Cynthia Zajac, Tomomi Toubai, MDPhD, Hideaki Fujiwara, Israel Henig, MD, Dan Peltier, MD, Pavan Reddy, MD

Blood (2017) 130 (Supplement 1): 2265.

https://doi.org/10.1182/blood.V130.Suppl_1.2265.2265

Published: 2017

Journal Articles

The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Antonio Gualberto, PhD MD, Catherine Scholz, PharmD, Matthew R Janes, PhD, Linda Kessler, BA, Azra Raza, MD

Blood (2017) 130 (Supplement 1): 3957.

https://doi.org/10.1182/blood.V130.Suppl_1.3957.3957

Published: 2017

Journal Articles

Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma

Arghya Ray, PhD, Deepika S DAS, PhD, Yan Song, PhD, Dharminder Chauhan, PhD, Kenneth C Anderson, MD

Blood (2017) 130 (Supplement 1): 1792.

https://doi.org/10.1182/blood.V130.Suppl_1.1792.1792

Published: 2017

Journal Articles

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Chloe Beate Steen, Ellen Leich, June Helen Myklebust, PhD, Sandra Lockmer, Jillian Frances Wise, Björn Engelbrekt Wahlin, Bjørn Østenstad, Knut Liestol, Eva Kimby, Andreas Rosenwald, Erlend Bremertun Smeland, Harald Holte, Ole Christian Lingjærde, Marianne Brodtkorb

Blood (2017) 130 (Supplement 1): 1467.

https://doi.org/10.1182/blood.V130.Suppl_1.1467.1467

Published: 2017

NARROW

RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma

The Role of Hypoxia on ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells

MCT1 As Molecularly Validated Predictive Marker for Lenalidomide-Maintenance Therapy in Multiple Myeloma

Polyunsaturated Fatty Acid (PUFA) Signaling Induces Ferroptosis-Mediated Cell-Death in Multiple Myeloma

Interferon-Gamma Induced Changes in Gene Expression Dramatically Alter Neutrophil Phenotype

CD25 (IL2RA) Is a Direct Transcriptional Target of PRDM1 in Activated Human Natural Killer Cells

Crosstalk between the IGF1 and CXCL12 Pathways Defines Objective Responses to the Farnesyl Transferase Inhibitor Tipifarnib in AML and PTCL Patients

SLAMF7 high CD16 negative Monocytes Increase in Peripheral Blood of Patients with Myelofibrosis in Correlation with JAK2V617F Mutation

Interleukin 1 Beta As a Promising Therapeutic Target in ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells

Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal

Upregulation of PD-L1 on Myeloma Cells By Immunomodulatory Agents Potentiates the Effect of Durvalumab

Targeting Tryptophan Catabolic Kynurenine Pathway Enhances Anti-Tumor Immunity and Cytotoxicity in Multiple Myeloma

Genotypic and Phenotypic Analysis of Adolescents with Heavy Menstrual Bleeding and Low Von Willebrand Activity - Interim Report of a Multi-Center Study

Identification of Alpha-Enolase (ENO1) As a Novel Immunometabolic Target in Multiple Myeloma

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

Pediatric LSC3 (pLSC3) Score Derived from DNMT3B-CD34-GPR56 As a Prognostic Tool to Predict AML Patient Outcome: Results from Two Independent Pediatric AML Cohorts

Metabolic Reprogramming of Dendritic Cells Is Controlled By the Mir-142

The CXCL12/CXCR4 Pathway As a Potential Target of Tipifarnib in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma

Combined Clinical and Gene Expression Score Identifies Follicular Lymphoma Patients with High Risk of Transformation in the Rituximab Era

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only